← FDA DRUG APPROVALS

FDA ANDA · ANDA087772

PREDNISONE

Sponsor: WATSON LABS

APPLICATION
ANDA087772
TYPE
ANDA
ORIGINAL APPROVAL
1982-07-13
LATEST ACTION
1999-07-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PREDNISONEDiscontinued
PREDNISONE 50MG · TABLET · ORAL

Approval history

1999-07-07Manufacturing (CMC) · Supplement 17AP
1998-03-30Manufacturing (CMC) · Supplement 16AP
1998-03-30Manufacturing (CMC) · Supplement 14AP
1998-03-30Manufacturing (CMC) · Supplement 15AP
1998-03-30Manufacturing (CMC) · Supplement 13AP
1996-04-01Manufacturing (CMC) · Supplement 12AP
1994-11-02Labeling · Supplement 11AP
1993-12-23Labeling · Supplement 10AP
1991-02-05Labeling · Supplement 9AP
1989-03-09Manufacturing (CMC) · Supplement 7AP
1986-12-11Manufacturing (CMC) · Supplement 4AP
1986-09-04Manufacturing (CMC) · Supplement 5AP
1982-07-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →